Fortune Drugs Limited
About Fortune Drugs Limited
Data last updated:
Fortune Drugs Limited is a public limited company based in Moga, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1991PLC011297. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors including Jasjit Gill (Managing Director) and Sohrab Singh Gill.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mehmamali Road Behind Focal Point, Moga, Punjab, India.
As per MCA filings, the company has open charges of ₹2.47 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Fortune Drugs has one previous CIN (Corporate Identification Number): L24232PB1991PLC011297. The current CIN is U24232PB1991PLC011297, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232PB1991PLC011297 | Current |
| L24232PB1991PLC011297 | Previous |
Contact details
Fortune Drugs Limited's registered office is in Moga, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMehmamali Road Behind Focal Point, Moga, Punjab, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Fortune Drugs Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Fortune Drugs Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fortune Drugs Limited, buy the company report.
Board of directors of Fortune Drugs Limited
Fortune Drugs has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sohrab Singh Gill | Director | 07 May 2019 | 7 Years 6 Months | Current |
| Abani Gill | Director | 31 May 2018 | 8 Years 5 Months | Current |
| Jasjit Gill | Managing Director | 02 Jul 2012 | 14 Years 4 Months | Current |
Auditor
Fortune Drugs Limited is audited by AGGARWAL ASHOK KUMAR AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGGARWAL ASHOK KUMAR AND ASSOCIATES | FY 2023 | 084649 |
Shareholding
The shareholding of Fortune Drugs Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fortune Drugs Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 1996 | 90170783 | Punjab State Ind. Development Corp. Ltd. | ₹50 Lakh | Open | |
| 04 Dec 1996 | 90171875 | Punjab State Ind. Development Corp. Ltd. | ₹1 Cr | Open | |
| 09 Feb 1994 | 90170638 | Canara Bank | ₹12 Lakh | Open | |
| 17 Sep 1992 | 90172620 | Punjab Financial Corporation | ₹84.6 Lakh | Open |
To see the full charge records of Fortune Drugs Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Fortune Drugs Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fortune Drugs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fortune Drugs has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Fortune Drugs Limited, buy the company report.
Recent activity
Fortune Drugs Limited has 9 board changes on record since 2012: 3 appointments and 6 cessations. The latest: Abani Gill ceased to be Additional Director on 30 Sep 2019.
6 earlier events are in the company report.
Frequently asked questions
Fortune Drugs is an active public limited company based in Moga, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 1991 (35+ years old) and is registered under CIN U24232PB1991PLC011297.
Fortune Drugs has 3 current directors:
- Jasjit Gill - Managing Director
- Sohrab Singh Gill - Director
- Abani Gill - Director
The latest financial statements of Fortune Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Fortune Drugs has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Fortune Drugs is U24232PB1991PLC011297. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fortune Drugs was incorporated on 24 April 1991, making it 35+ years old. It is registered with the Registrar of Companies, Chandigarh.
Abani Gill ceased to be Additional Director on 30 Sep 2019. Sohrab Singh Gill ceased to be Additional Director on 30 Sep 2019. Inderbir Singh Pannu ceased to be Director on 07 May 2019. Fortune Drugs has 9 board changes on record in total.
The registered office of Fortune Drugs is at Mehmamali Road Behind Focal Point, Moga, Punjab, India.
Fortune Drugs operates in the pharma industry, in the drug formulation and development segment.
Fortune Drugs has open charges of ₹2.47 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
